This inventor holds 1 USPTO granted patent. Top assignee: Laboratoire L. Lafon. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Frédéric Troalen: Innovator in Topoisomerase II Inhibition
Introduction
Frédéric Troalen is a notable inventor based in Bourg la Reine, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors that target topoisomerase II. His work is essential in advancing treatments for various diseases.
Latest Patents
Frédéric Troalen holds a patent for a Topoisomerase II inhibitor. This innovation is crucial for the development of new therapeutic strategies in cancer treatment and other related conditions. His patent portfolio reflects his commitment to enhancing medical science through innovative solutions.
Career Highlights
Troalen is currently associated with Laboratoire L. Lafon, where he applies his expertise in drug development. His role at the company allows him to work on cutting-edge research that has the potential to impact patient care positively. His dedication to his work is evident in the quality of his contributions.
Collaborations
Frédéric Troalen has collaborated with esteemed colleagues, including Valérie Frere-Gallois and Serge Fermandjian. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Frédéric Troalen is a distinguished inventor whose work in topoisomerase II inhibition is paving the way for advancements in medical treatments. His contributions to Laboratoire L. Lafon and collaborations with other professionals highlight his commitment to innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile